Takahashi, Nobunori
Asai, Shuji
Kobayakawa, Tomonori
Kaneko, Atsushi
Watanabe, Tatsuo
Kato, Takefumi
Nishiume, Tsuyoshi
Ishikawa, Hisato
Yoshioka, Yutaka
Kanayama, Yasuhide
Watanabe, Tsuyoshi
Hirano, Yuji
Hanabayashi, Masahiro
Yabe, Yuichiro
Yokota, Yutaka
Suzuki, Mochihito
Sobue, Yasumori
Terabe, Kenya
Ishiguro, Naoki
Kojima, Toshihisa
Article History
Received: 1 July 2020
Accepted: 2 December 2020
First Online: 14 December 2020
Competing interests
: N. T. has received research support and/or speakers’ fees from AbbVie, Bristol-Myers Squibb, Chugai, Eisai, Mitsubishi Tanabe, Asahi Kasei, Astellas, Pfizer, Janssen, Daiichi-Sankyo, Takeda, Eli Lilly, Novartis, and UCB Japan. S. A. has received speakers’ fees from AbbVie, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Janssen, Takeda, and UCB Japan. T. N. has received speakers’ fee from Eli Lilly. Y. H. has received speakers’ fees from AbbVie, Asahi Kasei, Astellas, Ayumi, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Janssen, Mitsubishi Tanabe, Nippon Kayaku, Pfizer, and UCB Japan. Y. Y. has received speakers’ fee from Asahi Kasei. M. S. has received speakers’ fees from Bristol-Myers Squibb, Eisai, and Asahi Kasei. Y. S. has received speakers’ fees from Astellas, Bristol-Myers Squibb, and Ono. N. I. has received grant/research support, consulting fees, and/or speakers’ fees from AbbVie, Asahi Kasei, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eisai, Eli Lilly, Kaken, Medical Corporation Sanjinkai, Medical Corporation Toukoukai, Mitsubishi Tanabe, Ono, Otsuka, Pfizer, Taisho Toyama, Takeda, and Zimmer Biomet. T. K. has received grant/research support and/or speakers’ fees from AbbVie, Astellas, Bristol-Myers Squibb, Chugai, Daiichi-Sankyo, Eli Lilly, Janssen, Mitsubishi Tanabe, Novartis, Pfizer, and Takeda. The other authors declare no conflicts of interest.